Skip to main content
TipRanks
Go Ultimate75% OFF

1933 Industries (TGIF) AI Stock Analysis

98 Followers
TSE:TGIF

1933 Industries

(CNQX:TGIF)

Select Model
Rating:43Neutral
Price Target:CAD 0.01â–²(0.00% Upside)
Action:reiterated
Date:07/01/26

The score is held down primarily by weak financial quality, especially the negative-equity balance sheet and inconsistent profitability. Technical momentum is also negative, while valuation offers some support through a low P/E ratio, but not enough to offset the higher fundamental risk.

Positive Factors
Improving cash generationConsistent positive free cash flow and operating cash flow indicate the business can internally fund some operations and capital needs. This strengthens near-term self-financing ability, supports earnings quality, and reduces absolute reliance on external financing if cash conversion momentum stabilizes.
Negative Factors
Weak balance sheet / negative equityNegative equity and sizable debt relative to assets materially constrain financial flexibility and increase solvency risk. This structure leaves the company vulnerable to cash-flow volatility, limits ability to raise unsecured capital, and raises default or restructuring risk if performance weakens.

1933 Industries (TGIF) vs. iShares MSCI Canada ETF (EWC)

-20%0%20%40%60%80%100%TSE:TGIF0.00%EWC+21.04%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
CAD 3.91M
Dividend Yield
―
Average Volume (3M)
208.80K
Price to Earnings (P/E)
4.7
Beta (1Y)
-1.53
Revenue Growth
-4.90%
EPS Growth
―
Country
Canada
Employees
85
Sector
Healthcare
Sector Strength
51
Industry
Drug Manufacturers - Specialty & Generic

1933 Industries Business Overview & Revenue Model

Company Description

1933 Industries Inc. is a Vancouver, Canada-based cannabis company engaged in the cultivation and production of cannabis products throughout the United States and Canada. The firm develops, packages, and markets an extensive range of cannabidiol (CBD...

How the Company Makes Money

1933 Industries makes money primarily by selling cannabis products through regulated, state-licensed cannabis supply chains. Key revenue streams include: (1) wholesale and/or direct sales of company-produced cannabis products (including manufactured/...

1933 Industries Financial Statement Overview

Summary

Financial performance is weak overall. The income statement shows flat to declining revenue momentum and unstable profitability, while the balance sheet is the main risk with negative equity and high leverage. Cash flow is improving and is now positive, but the gains are still fragile and have not offset the structural balance sheet weakness.

Income Statement

38Negative

Balance Sheet

24Negative

Cash Flow

52Neutral
Financial statement breakdown
BreakdownTTMOct 2025Jan 2025Oct 2023Oct 2022Oct 2021
Income Statement
Total Revenue16.51M17.45M19.35M18.27M12.54M11.98M
Gross Profit169.46K5.16M2.94M-4.22M2.69M4.82M
EBITDA-2.02M1.01M313.67K-10.03M-13.83M-2.71M
Net Income468.28K-217.04K-1.14M-13.36M-18.07M-6.29M
Balance Sheet
Total Assets15.53M16.80M16.87M18.02M29.01M45.35M
Cash, Cash Equivalents and Short-Term Investments536.57K545.98K449.18K1.09M363.27K4.41M
Total Debt15.57M17.60M16.78M17.57M17.68M17.87M
Total Liabilities18.80M21.40M21.70M23.28M21.49M20.12M
Stockholders Equity-3.27M-4.60M-3.53M-3.69M8.52M25.99M
Cash Flow
Free Cash Flow1.91M1.67M801.71K-2.33M-5.10M-5.12M
Operating Cash Flow2.08M1.84M1.69M-1.53M-5.09M-4.67M
Investing Cash Flow-318.84K-169.22K-890.78K2.33M1,581-456.36K
Financing Cash Flow-2.02M-1.58M-1.46M-266.55K1.53M6.06M

1933 Industries Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

TSE:TGIF against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
TSE:BBMTSE:BBM44NeutralCAD 4.95M-4.76-332.63%―-36.67%40.54%
TSE:TGIFTSE:TGIF43NeutralCAD 3.91M4.69-11.60%―-4.90%―
TSE:DHBTSE:DHB37UnderperformCAD 2.81M-1.25-67.83%―-35.46%-85.82%
TSE:PCLOTSE:PCLO23UnderperformCAD 8.41M-2.4128.59%―0.90%57.73%

* Healthcare Sector Average

Performance Comparison

0%100%200%TSE:TGIFTSE:DHBTSE:BBMTSE:PCLODec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
TSE:TGIF and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
TSE:TGIF1933 Industries, Inc.0.010.000.00%
TSE:DHBDelivra Health Brands Inc.0.09-0.20-68.97%
TSE:BBMBlueberries Medical0.01-0.01-50.00%
TSE:PCLOPharmacielo0.040.000.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Jul 01, 2026